Skip to main content

letter

. 1993 Jun 19;306(6893):1685. doi: 10.1136/bmj.306.6893.1685

Screening for ovarian cancer. Other malignancies cloud the issue.

PMCID: PMC1678058 PMID: 8324446

1685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Haglund C. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. Br J Cancer. 1986 Dec;54(6):897–901. doi: 10.1038/bjc.1986.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jacobs I., Davies A. P., Bridges J., Stabile I., Fay T., Lower A., Grudzinskas J. G., Oram D. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993 Apr 17;306(6884):1030–1034. doi: 10.1136/bmj.306.6884.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES